Cambridge Researchers Use AI to Create Super-Antigen Vaccine

Researchers at the University of Cambridge used AI to develop a super-antigen capable of defending against a family of mutating viruses. The vaccine targets coronaviruses and has undergone a human trial showing modest immune effects. It could accelerate vaccine development for Ebola, seasonal flu, and bird flu. The method uses genetic data from global virus surveillance programs to build a universal defense mechanism.